BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33178202)

  • 1. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
    Banda NK; Tomlinson S; Scheinman RI; Ho N; Ramirez JR; Mehta G; Wang G; Vu VP; Simberg D; Kulik L; Holers VM
    Front Immunol; 2020; 11():575154. PubMed ID: 33178202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
    Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
    J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
    Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
    Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
    Banda NK; Kraus DM; Muggli M; Bendele A; Holers VM; Arend WP
    J Immunol; 2003 Aug; 171(4):2109-15. PubMed ID: 12902517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis.
    Li Y; Wu S; Li Y; Jiang S; Lin T; Xia L; Shen H; Lu J
    Mol Biol Rep; 2016 Sep; 43(9):947-56. PubMed ID: 27379996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
    Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S
    J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoside exerts anti-inflammatory and anti-arthritic effects in LPS-stimulated human fibroblast-like synoviocytes in vitro and in mice with collagen-induced arthritis.
    Jin XN; Yan EZ; Wang HM; Sui HJ; Liu Z; Gao W; Jin Y
    Acta Pharmacol Sin; 2016 May; 37(5):674-86. PubMed ID: 27041460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
    Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S
    Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
    Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
    J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.
    Gui H; Liu X; Liu LR; Su DF; Dai SM
    Immunobiology; 2015 Jun; 220(6):817-22. PubMed ID: 25601571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice.
    Scarneo SA; Eibschutz LS; Bendele PJ; Yang KW; Totzke J; Hughes P; Fox DA; Haystead TAJ
    Arthritis Res Ther; 2019 Dec; 21(1):292. PubMed ID: 31847895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice.
    Dai S; Liu F; Ren M; Qin Z; Rout N; Yang XF; Wang H; Tomlinson S; Qin X
    Front Cardiovasc Med; 2021; 8():731315. PubMed ID: 34651027
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
    Banda NK; Levitt B; Glogowska MJ; Thurman JM; Takahashi K; Stahl GL; Tomlinson S; Arend WP; Holers VM
    J Immunol; 2009 Nov; 183(9):5928-37. PubMed ID: 19828624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin(22-52) combats inflammation and prevents systemic bone loss in murine collagen-induced arthritis.
    Ah Kioon MD; Asensio C; Ea HK; Velard F; Uzan B; Rullé S; Bazille C; Marty C; Falgarone G; Nguyen C; Collet C; Launay JM; Cohen-Solal M; Lioté F
    Arthritis Rheum; 2012 Apr; 64(4):1069-81. PubMed ID: 22006509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.
    Fridkis-Hareli M; Storek M; Or E; Altman R; Katti S; Sun F; Peng T; Hunter J; Johnson K; Wang Y; Lundberg AS; Mehta G; Banda NK; Michael Holers V
    Mol Immunol; 2019 Jan; 105():150-164. PubMed ID: 30513451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanidin-3-glucoside inhibits inflammatory activities in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis.
    Sun Y; Li L
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1038-1045. PubMed ID: 29779214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
    Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
    Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of arthritis in two murine models using antibodies to oncostatin M.
    Plater-Zyberk C; Buckton J; Thompson S; Spaull J; Zanders E; Papworth J; Life PF
    Arthritis Rheum; 2001 Nov; 44(11):2697-702. PubMed ID: 11710726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
    Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
    Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.